Abstract:Background
The burden of Non-Alcoholic Steatohepatitis is growing and current pharmacologic treatments are limited by adverse effects and inconsistent efficacy. Pilot studies suggest that Pentoxifylline and vitamin E can reduce degree and pattern of fatty liver, liver enzyme and inflammatory marker in patients with NASH.
Objectives
Evaluation of the clinical, biochemical and ultrasonographic effects of pentoxifylline, and vitamin E in patients with non-alcoholic steatohepatitis.
Meth… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.